10 Stocks Expected To Post Impressive Earnings This Week

7. Abbott Laboratories (NYSE:ABT)

Abbott Laboratories is a healthcare products provider that operates through medical devices, established pharmaceutical products, and other segments. The company’s Q3 performance was good as revenue grew 5% as compared to the previous year.

Now investors await the Q4 earning results which will be released on Wednesday. Abbott is projected to generate revenue worth $11.04 billion in Q4 while the EPS is estimated to clock in at $1.04. Wall Street analysts are bullish on the stock’s performance, indicating a 15% increase from the current price with an average target price of $130.54.

The stock struggled in the first half of 2024 but it regained in the second half. In the past five trading days, the stock’s performance suggests investors are optimistic about the earnings. The company is expected to continue attracting investor attention into 2025 because of its financial stability and attractive dividend yield of over 2%.